Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

The purpose was to describe first and subsequent relapses in patients from the OS2006/Sarcome-09 trial, to help future trial design. We prospectively collected and analysed relapse data of all French patients included in the OS2006/Sarcome-09 trial, who had achieved a first complete remission. 157 p...

Full description

Bibliographic Details
Main Authors: Eric Thebault, Sophie Piperno-Neumann, Diep Tran, Hélène Pacquement, Perrine Marec-Berard, Cyril Lervat, Marie-Pierre Castex, Morgane Cleirec, Emmanuelle Bompas, Jean-Pierre Vannier, Dominique Plantaz, Laure Saumet, Cecile Verite, Olivier Collard, Claire Pluchart, Claire Briandet, Laure Monard, Laurence Brugieres, Marie-Cécile Le Deley, Nathalie Gaspar
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
osteosarcoma
recurrence/relapse
phase-II trial
metastasis
RECIST
Online Access:https://www.mdpi.com/2072-6694/13/7/1683

Internet

https://www.mdpi.com/2072-6694/13/7/1683

Similar Items